Sign In Try for free

You’re previewing company data from public sources; information may vary from official SSM records

PHARMANIAGA BERHAD

Directors & Shareholders

2024 Financial Highlights

Revenue

RM3.8b

Profit After Tax

RM134m

Net Worth

RM-171m

Top 5 Shareholders

Other Companies You Might Be Interested In

Company Profile

Registration no. (Old / New): 467709M / 199801011581
Company Type: Public Limited
Date of Incorporation: 21 Aug 1998(27 years 4 months)
State
Status: Existing
Website: https://pharmaniaga.com/
Contact Number: 603 3342 9999
Auditor
Financial Year End: 31 Dec 2023
Business Sector: Investment Holding
MSIC
Registered Address
Business Address

Former Name

Name	Last Updated

Address Records

Address	Address Type	Last Updated
	Business / Registered
	Business / Registered

Total Issued

Type	Cash	Other than Cash	Total Issued Capital
Ordinary
Ordinary A
Ordinary B
Preference
Preference A
Preference B
Others
Other A
Other B
Total

Company Charges

Secured loans backed by company asset

Chargee	Date Created	Status
Creditor
Creditor

Directors / Officers

Name & IC	Designation	Residential Address
Dato' Abdul Razak Bin Jaafar	DIRECTOR since
Encik Zulkifli Bin Jafar	DIRECTOR since
Dato' Dr. H J Awaludin Bin Said	DIRECTOR since
Encik Mohammad Ashraf Bin Md. Radzi	DIRECTOR since
Mr. Mohd Firdaus Zulkifli	DIRECTOR since
Dr. Abdul Razak Bin Ahmad	DIRECTOR since
Ms. Norai'ni binti Mohamed Ali	OFFICER since
Encik Ahmad Shahredzuan Bin Mohd Shariff	OFFICER since
Dr. Badarulhisam Abdul Rahman	OFFICER since
Dr. Israfil Merican Fazil Merican	OFFICER since

Shareholders

Entity	Shares
Boustead Holdings Bhd	679,150,000 47.115%
Lembaga Tabung Angkatan Tentera	112,920,000 7.834%
East Navigators Capital Ltd	57,410,000 3.983%
Kenanga Investors Berhad	31,020,000 2.152%
Statens Pensjonsfond Utland	23,940,000 1.661%
Norges Bank Investment Management (NBIM)	23,940,000 1.661%
Minat Megah Sdn Bhd	23,380,000 1.622%
Tan (Boon Wy)	14,290,000 0.991%
Dasar Technologies Sdn. Bhd.	9,750,000 0.676%
Lodin bin Wok Kamaruddin	9,150,000 0.635%
OTHERS	456,510,559 31.67%
Total	1,441,460,559

Financials

Auditing History

Financial Year End	Audited By	Exempt Private Company	Consolidated Accounts	Unqualified Reports

Financial data is being retrieved from SSM and will be ready shortly.

Balance Sheet

Assets		2025	2024	2023
Non Current Assets
Current Assets
Total Assets YoY Growth

Liabilities		2025	2024	2023
Non Current Liabilities
Current Liabilities
Total Liabilities YoY Growth
Working Capital

Equity		2025	2024	2023
Share Capital
Retained Earnings
Share Premium & Reserve
Minority Interest
Net Worth YoY Growth

Income Statement

		2025	2024	2023
Revenue YoY Growth
Profit / (Loss) before tax YoY Growth
Profit / (Loss) after tax YoY Growth

Ratios

Liquidity		2025	2024	2023
Current Ratio
Working Capital Days

Profitability		2025	2024	2023
Return On Assets (ROA)
Return On Equity (ROE)
PBT Margin
PAT Margin
Return On Capital

Efficiency		2025	2024	2023
Current Asset Turnover
Total Asset Turnover
Non Current Asset Turnover
Working Capital Turnover

Leverage		2025	2024	2023
Gearing Ratio
Debt to Asset Ratio
Debt to Equity Ratio
Shareholders Equity Ratio

Other		2025	2024	2023
Dividend Pay-out Ratio
Earning / Share
Dividend / Share

Financial Year End	Audited By	Exempt Private Company	Consolidated Accounts	Unqualified Reports
31 Dec 2024	Auditor ID	No	Yes / No	Yes / No
31 Dec 2023	Auditor ID	No	Yes / No	Yes / No
31 Dec 2022	Auditor ID	No	Yes / No	Yes / No
31 Dec 2021	Auditor ID	No	Yes / No	Yes / No
31 Dec 2020	Auditor ID	No	Yes / No	Yes / No
31 Dec 2019	Auditor ID	No	Yes / No	Yes / No
31 Dec 2018	Auditor ID	No	Yes / No	Yes / No
31 Dec 2017	Auditor ID	No	Yes / No	Yes / No
31 Dec 2016	Auditor ID	No	Yes / No	Yes / No
31 Dec 2015	Auditor ID	No	Yes / No	Yes / No

Preview Full Report

Balance Sheet

Assets		2024	2023	2022	2021	2020
Non Current Assets
Current Assets
Total Assets YoY Growth		1,964,970,000	1,862,780,000 -5.20%	1,791,710,000 -3.82%	2,224,790,000 24.17%	1,529,740,000 -31.24%

Liabilities		2024	2023	2022	2021	2020
Non Current Liabilities
Current Liabilities
Total Liabilities YoY Growth		2,163,580,000	2,213,920,000 2.33%	2,067,500,000 -6.61%	1,807,400,000 -12.58%	1,242,630,000 -31.25%
Working Capital		0	0	0	0	0

Equity		2024	2023	2022	2021	2020
Share Capital
Retained Earnings		(471,410,000)	(603,420,000)	(404,270,000)	293,730,000	181,740,000
Share Premium & Reserve
Minority Interest
Net Worth YoY Growth		(171,280,000)	(299,070,000) -74.61%	(248,740,000) 16.83%	450,460,000 281.10%	337,530,000 -25.07%

Income Statement

		2024	2023	2022	2021	2020
Revenue YoY Growth		3,759,480,000	3,404,480,000 -9.44%	3,510,680,000 3.12%	4,815,020,000 37.15%	2,725,070,000 -43.40%
Profit / (Loss) before tax YoY Growth		194,180,000	(78,160,000) -140.25%	(580,850,000) -643.16%	277,070,000 147.70%	35,790,000 -87.08%
Taxation		60,390,000	580,000	24,200,000	104,860,000	9,520,000
Profit / (Loss) after tax YoY Growth		133,790,000	(78,740,000) -158.85%	(605,050,000) -668.42%	172,210,000 128.46%	26,270,000 -84.75%

Cash Flow

		2024	2023	2022	2021	2020
Cash & Equivalents at Begining of the Year
Operation activities
Net cashflows from operations
Investment activities
Net cashflows from Investment
Financing activities
Net cashflows from Financing
Net increase in cash and cash equivalents
Cash & Equivalents at End of Year

Ratios

Liquidity		2024	2023	2022	2021	2020
Current Ratio
Working Capital Days

Profitability		2024	2023	2022	2021	2020
Return On Assets (ROA)
Return On Equity (ROE)
PBT Margin
PAT Margin
Return On Capital

Efficiency		2024	2023	2022	2021	2020
Current Asset Turnover
Total Asset Turnover
Non Current Asset Turnover
Working Capital Turnover

Leverage		2024	2023	2022	2021	2020
Gearing Ratio
Debt to Asset Ratio
Debt to Equity Ratio
Shareholders Equity Ratio

Other		2024	2023	2022	2021	2020
Dividend Pay-out Ratio
Earning / Share
Dividend / Share